World News
Home > World News
Rutgers clinical trial: New drug could help prevent serious illness, death in early-stage COVID-19 patients
TIWN
TIWN
PHOTO : TIWN
New York, May 8 (TIWN): Rutgers University has launched a clinical trial to test the safety and efficacy of a new drug that could help prevent serious illness and death in early-stage COVID-19 patients.
The drug is called EDP1815. It is administered orally, and is said to be anti-inflammatory and very safe. It will be given to newly hospitalized COVID-19 patients at Robert Wood Johnson University Hospital.
Add your Comment
Comments (0)
More World News
- A conviction can cost Trump his vote, some Republican support: Analysis
- India exemplifies how digital revolution can become accessible to millions: UNGA President
- Hundreds of students arrested across US in surging pro-Palestine protests
- North Korea touts ties with Russia on Kim-Putin summit anniversary
- UN resolution against arms race in space fails due to Russian veto